Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically.

PubWeight™: 2.61‹?› | Rank: Top 1%

🔗 View Article (PMC 297874)

Published in Proc Natl Acad Sci U S A on September 01, 1989

Authors

A Sarai1, Y Takeda

Author Affiliations

1: Laboratory of Mathematical Biology, National Cancer Institute, Bethesda, MD 20892.

Articles citing this

Non-independence of Mnt repressor-operator interaction determined by a new quantitative multiple fluorescence relative affinity (QuMFRA) assay. Nucleic Acids Res (2001) 3.63

Physical constraints and functional characteristics of transcription factor-DNA interaction. Proc Natl Acad Sci U S A (2002) 3.07

Inferring binding energies from selected binding sites. PLoS Comput Biol (2009) 2.66

Cooperativity in long-range gene regulation by the lambda CI repressor. Genes Dev (2004) 2.65

Octamerization of lambda CI repressor is needed for effective repression of P(RM) and efficient switching from lysogeny. Genes Dev (2001) 2.53

Protein-DNA binding specificity predictions with structural models. Nucleic Acids Res (2005) 2.45

Using deep sequencing to characterize the biophysical mechanism of a transcriptional regulatory sequence. Proc Natl Acad Sci U S A (2010) 2.32

Adaptive evolution of transcription factor binding sites. BMC Evol Biol (2004) 2.03

Functional borders, genetic fine structure, and distance requirements of cis elements mediating light responsiveness of the parsley chalcone synthase promoter. Proc Natl Acad Sci U S A (1990) 1.84

Mutant lac repressors with new specificities hint at rules for protein--DNA recognition. EMBO J (1990) 1.77

Length-encoded multiplex binding site determination: application to zinc finger proteins. Proc Natl Acad Sci U S A (1994) 1.76

Protein-DNA conformational changes in the crystal structure of a lambda Cro-operator complex. Proc Natl Acad Sci U S A (1990) 1.63

Recognition of specific DNA sequences by the c-myb protooncogene product: role of three repeat units in the DNA-binding domain. Proc Natl Acad Sci U S A (1993) 1.55

Modeling the specificity of protein-DNA interactions. Quant Biol (2013) 1.50

Cro's role in the CI Cro bistable switch is critical for {lambda}'s transition from lysogeny to lytic development. Genes Dev (2007) 1.31

Predicting strength and function for promoters of the Escherichia coli alternative sigma factor, sigmaE. Proc Natl Acad Sci U S A (2010) 1.23

From biophysics to evolutionary genetics: statistical aspects of gene regulation. BMC Bioinformatics (2007) 1.22

Additive, cooperative and anti-cooperative effects between identity nucleotides of a tRNA. EMBO J (1993) 1.22

Electrostatic contributions to the binding free energy of the lambdacI repressor to DNA. Biophys J (1998) 1.20

Motifs emerge from function in model gene regulatory networks. Proc Natl Acad Sci U S A (2011) 1.19

Multilevel autoregulation of λ repressor protein CI by DNA looping in vitro. Proc Natl Acad Sci U S A (2011) 1.18

Stochastic expression dynamics of a transcription factor revealed by single-molecule noise analysis. Nat Struct Mol Biol (2012) 1.14

Identification of base and backbone contacts used for DNA sequence recognition and high-affinity binding by LAC9, a transcription activator containing a C6 zinc finger. Mol Cell Biol (1991) 1.14

Consistencies of individual DNA base-amino acid interactions in structures and sequences. Nucleic Acids Res (1995) 1.13

How Cro and lambda-repressor distinguish between operators: the structural basis underlying a genetic switch. Proc Natl Acad Sci U S A (1998) 1.07

Stability and instability in the lysogenic state of phage lambda. J Bacteriol (2010) 1.03

Genetic analysis of the Tn21 mer operator-promoter. J Bacteriol (1992) 0.99

A general procedure for locating and analyzing protein-binding sequence motifs in nucleic acids. Proc Natl Acad Sci U S A (1998) 0.98

Binding site analysis of c-Myb: screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements. Nucleic Acids Res (1996) 0.97

Transcription-factor-mediated DNA looping probed by high-resolution, single-molecule imaging in live E. coli cells. PLoS Biol (2013) 0.96

Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res (2007) 0.96

Specificity of DNA recognition in the nucleoprotein complex for site-specific recombination by Tn21 resolvase. Nucleic Acids Res (1993) 0.96

RNA base-amino acid interaction strengths derived from structures and sequences. Nucleic Acids Res (1997) 0.95

Base-pair opening and spermine binding--B-DNA features displayed in the crystal structure of a gal operon fragment: implications for protein-DNA recognition. Nucleic Acids Res (1995) 0.93

Modeling the quantitative specificity of DNA-binding proteins from example binding sites. PLoS One (2009) 0.91

ACTIVITY: a database on DNA/RNA sites activity adapted to apply sequence-activity relationships from one system to another. Nucleic Acids Res (2001) 0.90

Cooperative DNA binding by CI repressor is dispensable in a phage lambda variant. Proc Natl Acad Sci U S A (2007) 0.89

Evolutionary meandering of intermolecular interactions along the drift barrier. Proc Natl Acad Sci U S A (2014) 0.89

Specificity of the Mnt protein determined by binding to randomized operators. Proc Natl Acad Sci U S A (1991) 0.88

An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus. MBio (2015) 0.87

High-resolution specificity from DNA sequencing highlights alternative modes of Lac repressor binding. Genetics (2014) 0.86

Identification of DNA-binding protein target sequences by physical effective energy functions: free energy analysis of lambda repressor-DNA complexes. BMC Struct Biol (2007) 0.85

Non-additivity of sequence-specific enzyme-DNA interactions in the EcoRI DNA methyltransferase. Nucleic Acids Res (1991) 0.85

Bioinformatic analysis of the protein/DNA interface. Nucleic Acids Res (2013) 0.84

Sequence-specific cleavage of dsRNA by Mini-III RNase. Nucleic Acids Res (2015) 0.84

Operator binding by lambda repressor heterodimers with one or two N-terminal arms. Proc Natl Acad Sci U S A (1995) 0.81

An altered-specificity mutation in a human POU domain demonstrates functional analogy between the POU-specific subdomain and phage lambda repressor. Proc Natl Acad Sci U S A (1994) 0.81

Scanning sequences after Gibbs sampling to find multiple occurrences of functional elements. BMC Bioinformatics (2006) 0.80

A universal scaling law determines time reversibility and steady state of substitutions under selection. Theor Popul Biol (2012) 0.79

The role of repressor kinetics in relief of transcriptional interference between convergent promoters. Nucleic Acids Res (2016) 0.79

Role of cis-acting sites in stimulation of the phage λ P(RM) promoter by CI-mediated looping. J Bacteriol (2013) 0.78

High-affinity quasi-specific sites in the genome: how the DNA-binding proteins cope with them. Biophys J (2011) 0.77

The challenge-phage assay reveals differences in the binding equilibria of mutant Escherichia coli Trp super-repressors in vivo. Nucleic Acids Res (1993) 0.77

Switching DNA-binding specificity by unnatural amino acid substitution. Nucleic Acids Res (2005) 0.75

Thermodynamic Additivity for Impacts of Base-Pair Substitutions on Association of the Egr-1 Zinc-Finger Protein with DNA. Biochemistry (2016) 0.75

Communication between binding sites is required for YqjI regulation of target promoters within the yqjH-yqjI intergenic region. J Bacteriol (2014) 0.75

Indirect read-out of the promoter DNA by RNA polymerase in the closed complex. Nucleic Acids Res (2012) 0.75

Articles cited by this

A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51

Protein-DNA recognition. Annu Rev Biochem (1984) 22.02

Lac repressor-operator interaction. I. Equilibrium studies. J Mol Biol (1970) 13.32

Crystal structure of trp repressor/operator complex at atomic resolution. Nature (1988) 7.34

How the lambda repressor and cro work. Cell (1980) 6.65

The operator-binding domain of lambda repressor: structure and DNA recognition. Nature (1982) 6.03

Structure of the DNA-Eco RI endonuclease recognition complex at 3 A resolution. Science (1986) 4.89

Structure of the lambda complex at 2.5 A resolution: details of the repressor-operator interactions. Science (1988) 4.67

Recognition of a DNA operator by the repressor of phage 434: a view at high resolution. Science (1988) 4.60

lambda Repressor and cro--components of an efficient molecular switch. Nature (1981) 4.52

Mechanism of action of the cro protein of bacteriophage lambda. Proc Natl Acad Sci U S A (1978) 4.34

Recognition sequences of repressor and polymerase in the operators of bacteriophage lambda. Cell (1975) 4.28

Mutations in lambda repressor's amino-terminal domain: implications for protein stability and DNA binding. Proc Natl Acad Sci U S A (1983) 3.67

DNA-binding proteins. Science (1983) 3.56

Bacteriophage lambda repressor and cro protein: interactions with operator DNA. Methods Enzymol (1980) 3.52

The N-terminal arms of lambda repressor wrap around the operator DNA. Nature (1982) 2.90

Analysis of the sequence-specific interactions between Cro repressor and operator DNA by systematic base substitution experiments. Proc Natl Acad Sci U S A (1989) 2.76

Structure of the operator-binding domain of bacteriophage lambda repressor: implications for DNA recognition and gene regulation. Cold Spring Harb Symp Quant Biol (1983) 2.15

Structure of a phage 434 Cro/DNA complex. Nature (1988) 1.98

Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85

Completed DNA sequences and organization of repressor-binding sites in the operators of phage lambda. J Mol Biol (1977) 1.66

NH2-terminal arm of phage lambda repressor contributes energy and specificity to repressor binding and determines the effects of operator mutations. Proc Natl Acad Sci U S A (1985) 1.36

DNA site recognition and reduced specificity of the Eco RI endonuclease. J Biol Chem (1980) 1.35

Articles by these authors

(truncated to the top 100)

Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol (1999) 16.86

Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22

Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan. J Clin Microbiol (1997) 4.53

Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis (1994) 3.91

Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb Pathog (1990) 3.88

DNA-binding proteins. Science (1983) 3.56

The molecular basis of DNA-protein recognition inferred from the structure of cro repressor. Nature (1982) 3.56

Immunological nonidentity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect Immun (1981) 3.46

Modified Elek test for detection of heat-labile enterotoxin of enterotoxigenic Escherichia coli. J Clin Microbiol (1981) 3.37

Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol (1991) 3.32

Production of cholera-like enterotoxin by a Vibrio cholerae non-O1 strain isolated from the environment. Infect Immun (1981) 3.21

Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun (1990) 3.17

Identification of lethal toxin with the thermostable direct hemolysin produced by Vibrio parahaemolyticus, and some physicochemical properties of the purified toxin. Infect Immun (1976) 3.11

Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol (1998) 2.98

Detection of the thermostable direct hemolysin gene and related DNA sequences in Vibrio parahaemolyticus and other vibrio species by the DNA colony hybridization test. Infect Immun (1985) 2.90

Amino-acid sequence of a heat-stable enterotoxin produced by human enterotoxigenic Escherichia coli. Eur J Biochem (1982) 2.78

Non-O1 Vibrio cholerae hemolysin: purification, partial characterization, and immunological relatedness to El Tor hemolysin. Infect Immun (1984) 2.72

Clonal diversity among recently emerged strains of Vibrio parahaemolyticus O3:K6 associated with pandemic spread. J Clin Microbiol (1999) 2.66

Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J Clin Microbiol (1985) 2.66

Vibrio cholerae O139 Bengal in Bangkok. Lancet (1993) 2.64

Purification and some properties of a non-o1 Vibrio cholerae enterotoxin that is identical to cholera enterotoxin. Infect Immun (1983) 2.62

Isolation of a factor causing morphological changes of chinese hamster ovary cells from the culture filtrate of Vibrio parahaemolyticus. Infect Immun (1976) 2.56

Purification and partial characterization of heat-stable enterotoxin of enterotoxigenic Escherichia coli. Infect Immun (1979) 2.55

Demonstration of the cardiotoxicity of the thermostable direct hemolysin (lethal toxin) produced by Vibrio parahaemolyticus. Infect Immun (1976) 2.51

Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur J Immunol (1990) 2.44

Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog (1995) 2.27

Molecular evidence of clonal Vibrio parahaemolyticus pandemic strains. Emerg Infect Dis (2001) 2.24

Detection of the thermostable direct hemolysin gene (tdh) and the thermostable direct hemolysin-related hemolysin gene (trh) of Vibrio parahaemolyticus by polymerase chain reaction. Mol Cell Probes (1992) 2.22

Synthetic ColE1 plasmids carrying genes for cell division in Escherichia coli. Plasmid (1977) 2.22

Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis. J Clin Microbiol (1996) 2.21

Virulence genes in environmental strains of Vibrio cholerae. Appl Environ Microbiol (2000) 2.21

Amino acid sequence of Cro regulatory protein of bacteriophage lambda. Nature (1977) 2.18

Sequence variation in the thermostable direct hemolysin-related hemolysin (trh) gene of Vibrio parahaemolyticus. Appl Environ Microbiol (1992) 2.16

Immunological methods for detection of Kanagawa phenomenon of Vibrio parahaemolyticus. J Clin Microbiol (1980) 2.15

In vitro formation of hybrid toxins between subunits of Escherichia coli heat-labile enterotoxin and those of cholera enterotoxin. Infect Immun (1981) 2.12

Economic recession and health inequalities in Japan: analysis with a national sample, 1986-2001. J Epidemiol Community Health (2008) 2.11

Structure of the DNA-binding region of lac repressor inferred from its homology with cro repressor. Proc Natl Acad Sci U S A (1982) 2.09

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A (1997) 2.07

Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum (1998) 2.01

DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci U S A (1994) 2.01

Thermostable direct hemolysin of Vibrio parahaemolyticus. Pharmacol Ther (1982) 2.01

Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect (2000) 1.96

Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol (1998) 1.94

Isolation of special antibodies which react only with homologous enterotoxins from Vibrio cholerae and Enterotoxigenic Escherichia coli. Infect Immun (1981) 1.94

Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin. Infect Immun (1983) 1.93

Ribosomes from Escherichia coli merodiplods heterozygous for resistance to streptomycin and to spectinomycin. J Mol Biol (1968) 1.92

Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb Pathog (1987) 1.90

Existence of two distinct hemolysins in Vibrio parahaemolyticus. Infect Immun (1974) 1.90

Further evaluation of the Biken test (modified Elek test) for detection of enterotoxigenic Escherichia coli producing heat-labile enterotoxin and application of the test to sampling of heat-stable enterotoxin. J Clin Microbiol (1982) 1.89

Amino acid sequence of a heat-stable enterotoxin isolated from enterotoxigenic Escherichia coli strain 18D. FEBS Lett (1983) 1.85

Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85

Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol Immunol (1993) 1.84

Structure and gene expression of the E. coli Mn-superoxide dismutase gene. Nucleic Acids Res (1986) 1.83

Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol (1995) 1.83

Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun (1997) 1.80

A thermolabile direct hemolysin of Vibrio parahaemolyticus. Biken J (1969) 1.80

Virulence patterns of Vibrio cholerae non-O1 strains isolated from hospitalised patients with acute diarrhoea in Calcutta, India. J Med Microbiol (1993) 1.80

Cro regulatory protein specified by bacteriophage lambda. Structure, DNA-binding, and repression of RNA synthesis. J Biol Chem (1977) 1.78

Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2). Microb Pathog (1989) 1.78

Effect of heat (Arrhenius effect) on crude hemolysin of Vibrio parahaemolyticus. Infect Immun (1972) 1.78

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther (2008) 1.77

The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76

Characterization of VPI pathogenicity island and CTXphi prophage in environmental strains of Vibrio cholerae. J Bacteriol (2001) 1.76

Antigenic difference between polar montrichous and peritrichous flagella of Vibrio parahaemolyticus. J Bacteriol (1974) 1.69

Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol (1999) 1.69

Emergence of a restricted bioserovar of Vibrio parahaemolyticus as the predominant cause of Vibrio-associated gastroenteritis on the West Coast of the United States and Mexico. J Clin Microbiol (1989) 1.68

Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen. J Clin Invest (1966) 1.64

Protein-DNA conformational changes in the crystal structure of a lambda Cro-operator complex. Proc Natl Acad Sci U S A (1990) 1.63

Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med (2000) 1.62

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med (1997) 1.61

Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol Immunol (1988) 1.61

The evolution of genomic imprinting. Genetics (1996) 1.59

Essential structure for full enterotoxigenic activity of heat-stable enterotoxin produced by enterotoxigenic Escherichia coli. FEBS Lett (1985) 1.57

Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J Clin Microbiol (2010) 1.56

Evidence for insertion sequence-mediated spread of the thermostable direct hemolysin gene among Vibrio species. J Bacteriol (1991) 1.55

Clonal dissemination of Vibrio parahaemolyticus displaying similar DNA fingerprint but belonging to two different serovars (O3:K6 and O4:K68) in Thailand and India. Epidemiol Infect (2000) 1.54

Purification and properties of a DNA-binding protein with characteristics expected for the Cro protein of bacteriophage lambda, a repressor essential for lytic growth. Proc Natl Acad Sci U S A (1976) 1.54

Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents. Antimicrob Agents Chemother (1995) 1.54

Two sporadic cases of Liddle's syndrome caused by De novo ENaC mutations. Am J Kidney Dis (2001) 1.52

Synthetic ColE1 Plasmids carrying genes for penicillin-binding proteins in Escherichia coli. Plasmid (1981) 1.52

Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C. J Gastroenterol Hepatol (1999) 1.51

Spontaneous regression of hepatocellular carcinoma and review of literature. J Gastroenterol Hepatol (2000) 1.50

Traditional medicine in Turkey X. Folk medicine in Central Anatolia. J Ethnopharmacol (2001) 1.50

Resurgence of Vibrio cholerae O139 Bengal with altered antibiogram in Calcutta, India. Lancet (1996) 1.49

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer (2010) 1.48

Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb Pathog (1987) 1.47

Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells. Acta Haematol (1992) 1.46

A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A (2001) 1.46

Demonstration of a temperature-dependent inactivating factor of the thermostable direct hemolysin in Vibrio parahaemolyticus. Infect Immun (1974) 1.46

Brunner's gland adenoma with a focus of p53-positive atypical glands. J Gastroenterol (2000) 1.46

Traditional medicine in Turkey. V. Folk medicine in the inner Taurus Mountains. J Ethnopharmacol (1995) 1.46

Isolation and partial purification of thermolabile direct hemolysin of Vibrio parahaemolyticus. Biken J (1972) 1.45

Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis (2000) 1.45

A functional comparison of animal anterior cruciate ligament models to the human anterior cruciate ligament. Ann Biomed Eng (1998) 1.45

Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol (1997) 1.44

Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab (1978) 1.42

Cryptic appearance of a new clone of Vibrio cholerae serogroup 01 biotype El Tor in Calcutta, India. Microbiol Immunol (1997) 1.42

Cell vacuolation, a manifestation of the El tor hemolysin of Vibrio cholerae. Infect Immun (2000) 1.41

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat (2006) 1.39